£193k
vs Mar 2025Active15556809Private limited companyOxford
OJAS IMMUNE LIMITED
Significant control: Aroul Selvam Ramadass (25–50%), Subhankar Mukhopadhyay (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Ojas Immune Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Ojas Immune Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
OJAS IMMUNE LIMITED is an active private limited company (company number 15556809) incorporated on 12 March 2024, registered in Oxford. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 March 2026, showing net assets of £193k, with 3 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 1783% on the prior period (−£11k).
Peer position · net assets
By net assets it sits in the upper half of 152 comparable companies in Oxford (median £10k, upper quartile £474k).
02
Ownership and control
- Dr. Aroul Selvam Ramadass
- owns 25–50% of shares
- Dr Subhankar Mukhopadhyay
- owns 25–50% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 12 March 20242 yrs ago
- Next accounts due
- 31 December 2027in 431 days
- Confirmation statement due
- 26 March 2027in 151 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
3
vs Mar 2025| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2026 | £193k | — | — | — | — | — | 3 |
| 31 March 2025 | −£11k | — | — | — | — | — | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets above zeroNet assets £193,148 at 31 March 2026
- Net assets up 10% or more on the prior period+1783.4% vs prior period
- Incorporated two to five years agoIncorporated 12 March 2024
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 431 days
- Confirmation statement duein 151 days
- Accounts period endNet assets £193k · micro accounts
- Accounts period endNet liabilities £11k · micro accounts
- Incorporated
08
Similar companies in Oxford
- LB BIO LTDOxford · inc. Mar 2024
- BIOMERGY LTDBanbury · inc. Feb 2024
- SANDBOX BIOSCIENCE LTDChipping Norton · inc. Apr 2024
- MELIO BIO LIMITEDOxford · inc. Feb 2024
- ICOSPHERE BIOSCIENCES LTDOxford · inc. Apr 2024
- RE-AIM THERAPEUTICS LTDOxford · inc. Apr 2024
All companies incorporated on 12 March 2024 · in Mar 2024.
09
Reminders for OJAS IMMUNE LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.